Global Clinical Pharmacology
Executive Summary
Joint venture between Hospital Corp. of America and the Institute of Clinical Pharmacology established to manage clinical research using HCA hospitals. ICP will own 80% of the joint venture and contribute its worldwide medical research operations. Global, headquartered in Nashville on the HCA campus, will be headed by ICP Chairman and CEO Austin Darragh. HCA is putting up $2.6 mil. for its 20% stake.